Q4 2021 Holdings
Filed 2022-02-14 | 97 holdings | $990.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medicus Sciences Acquisition | *W EXP 02/12/202 | G5960S124 | $42 | 57,770 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $189 | 99,999 | 0.0% |
| Somalogic Inc | *W EXP 08/31/202 | 83444K113 | $220 | 65,999 | 0.0% |
| Ziopharm Oncology Inc | COM | 98973P101 | $643 | 590,000 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $1.4K | 165,000 | 0.0% |
| Social Cap Suvretta Hlds CP | CLASS A ORD SHS | G8253Y105 | $2.0K | 200,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253U103 | $2.0K | 200,000 | 0.0% |
| Social Cap Suvretta HLD Crpi | CLASS A ORD SHS | G8253W109 | $2.0K | 200,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253T106 | $2.0K | 200,000 | 0.0% |
| Oncosec MED Inc | COM | 68234L306 | $2.8K | 2,945,000 | 0.0% |
| Merus N V | COM | N5749R100 | $3.3K | 103,000 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $3.8K | 330,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.0K | 400,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0K | 400,000 | 0.0% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $4.2K | 950,000 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $4.4K | 255,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $4.9K | 500,000 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $4.9K | 394,000 | 0.0% |
| Dynamics Special Purpose COR | CLASS A COM | 268010105 | $4.9K | 500,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $5.0K | 500,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $5.0K | 520,000 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $5.8K | 485,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $6.1K | 300,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $6.4K | 827,402 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $6.8K | 1,000,000 | 0.0% |
| Definitive Healthcare Corp(DH) | CLASS A COM | 24477E103 | $6.8K | 250,000 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $7.0K | 455,037 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $7.0K | 408,140 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $7.7K | 705,000 | 0.0% |
| Field Trip Health LTD | COM | 31656R102 | $7.9K | 3,205,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $8.8K | 710,000 | 0.0% |
| Sentinelone Inc(S) | CL A | 81730H109 | $10.5K | 208,000 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $11.0K | 1,514,410 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $11.5K | 4,405,000 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $13.7K | 2,239,278 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $16.5K | 731,536 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $18.6K | 1,345,000 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $21.0K | 1,849,538 | 0.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $21.9K | 987,400 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $23.5K | 644,400 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $25.2K | 862,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $25.3K | 1,278,261 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $27.4K | 2,010,000 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $29.3K | 700,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $30.4K | 3,775,000 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $33.2K | 711,900 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $34.9K | 2,460,000 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $37.3K | 1,896,000 | 0.0% |
| Ortho Clinical Diagnostics H | ORD SHS | G6829J107 | $38.3K | 1,790,000 | 0.0% |